HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)piperazine → cis-7-{4-[4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-but-2-envioxy}-2-methyl-benzothiazole
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)piperazine | HCID 2735936 | — |
| Reactant | 1,4-Dichloro-cis-2-butene | HCID 6432115 | — |
| Reactant | cis-7-(3-Chloroallyloxy)-2-methyl-benzothiazole | HCID 86755936 | — |
| Product | cis-7-{4-[4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-but-2-envioxy}-2-methyl-benzothiazole | HCID 67851631 | — |
| Product | cis-7-(3-Chloroallyloxy)-2-methyl-benzothiazole | HCID 86755936 | — |
Reaction Steps
The title compound was prepared according to Method GA from cis-7-(3-chloroallyloxy)-2-methyl-benzothiazole and 1-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)piperazine. mp 114° C.; LSIMS m/z 496. The cis-7-(3-chloro-allyloxy)-2-methyl-benzothiazole was prepared by Method IV, with cis-1,4-dichloro-2-butene as the alkylating agent.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06130217 |
| Source dataset | uspto-grants-2000_10 |
| ORD ID | ord-e00a9f5c77f841b29a420b447aaf9417 |
| Source note | uspto-grants-2000_10 |